Novavax
NVAX
222 hedge funds and large institutions have $417M invested in Novavax in 2023 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 79 increasing their positions, 53 reducing their positions, and 53 closing their positions.
49% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 53
7.84% more ownership
Funds ownership: 61.91% → 69.75% (+7.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less funds holding
Funds holding: 252 → 222 (-30)
13% less call options, than puts
Call options by funds: $87.5M | Put options by funds: $101M
23% less capital invested
Capital invested by funds: $540M → $417M (-$124M)
45% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 53
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$46.2M |
| 2 |
SCM
Shah Capital Management
Raleigh,
North Carolina
|
+$32.5M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$15.9M |
| 4 |
Coatue Management
New York
|
+$13.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VA
VR Adviser
New York
|
-$19.3M |
| 2 |
HIG
Herr Investment Group
Austin,
Texas
|
-$14.4M |
| 3 |
Millennium Management
New York
|
-$13.8M |
| 4 |
CCM
CAAS Capital Management
New York
|
-$10.3M |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$8.74M |
NVAX Hedge Fund Activity: Q1 2023 in Review
222 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q1 2023, worth a combined $417M — down 23% from $540M a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of NVAX and 29 opened new positions — a net loss of 24 holders — while 53 trimmed existing stakes and 79 added.
The largest buyer was State Street, adding an estimated $46.2M. The largest seller was VR Adviser, exiting entirely with an estimated $19.3M sold.
- 222 institutional investors held Novavax (NVAX) as of Q1 2023, down from 252 in Q4 2022.
- Funds reported $417M of Novavax stock for Q1 2023, down 23% quarter-over-quarter.
- 29 funds opened new Novavax positions in Q1 2023 and 53 closed out, a net change of -24 holders.
- The largest Novavax buyer in Q1 2023 was State Street, an estimated $46.2M added.
- The largest Novavax seller in Q1 2023 was VR Adviser, an estimated $19.3M sold.
Based on aggregated 13F filings for Q1 2023.